Xiao‐Ping Shi
Biographic Data
| ID | 10242879 |
|---|---|
| NAME | Xiao‐Ping Shi |
| GIVEN NAMES | Xiao‐Ping |
| FAMILY NAME | Shi |
| SIGNATURE | SHI X P |
| AFFILIATIONS | Sun Yat-sen University |
| ORCID | 0000-0002-3272-5554 |
| VERIFIED | Yes |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 1 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
Pharmacoeconomic evaluation of isavuconazole, posaconazole, and voriconazole for the treatment of invasive mold diseases in hematological patients
Background Invasive mold diseases (IMD) is associated with high mortality and a substantial economic burden. For high-risk patients, fever drive or diagnostic drive therapy is usually initiated prior to the differential diagnosis of the pathogen. This study evaluated the cost-effectiveness of isavuconazole, posaconazole, vs. voriconazole in the treatment of IMD from the perspective of the Chinese healthcare system, informing healthcare decision-m…
No prominent works on this page.
Pharmacoeconomic evaluation of isavuconazole, posaconazole, and voriconazole for the treatment of invasive mold diseases in hematological patients
Background Invasive mold diseases (IMD) is associated with high mortality and a substantial economic burden. For high-risk patients, fever drive or diagnostic drive therapy is usually initiated prior to the differential diagnosis of the pathogen. This study evaluated the cost-effectiveness of isavuconazole, posaconazole, vs. voriconazole in the treatment of IMD from the perspective of the Chinese healthcare system, informing healthcare decision-m…
Antifungal (1 work) · Antifungal resistance and susceptibility (1 work) · Cost effectiveness (1 work) · Cost-effectiveness analysis (1 work) · Fungal Infections and Studies (1 work) · Infectious Diseases and Mycology (1 work) · Intensive care medicine (1 work) · Internal Medicine (1 work) · Medicine (1 work) · Posaconazole (1 work)